Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02703571
Title Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
Yale University School of Medicine New Haven Connecticut 06520 United States Details
University of Miami Sylvester Comp Cancer Ctr Miami Florida 33136 United States Details
Dana Farber Cancer Center Boston Massachusetts 02215 United States Details
UT MD Anderson Cancer Center Houston Texas 77030 United States Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Edmonton Alberta T6G 1Z2 Canada Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Utrecht 3584 CX Netherlands Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field